NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 46 filers reported holding NEXTCURE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,497,207 | -28.3% | 2,711,013 | 0.0% | 0.07% | -15.9% |
Q2 2023 | $4,879,823 | +21.6% | 2,711,013 | 0.0% | 0.09% | +11.4% |
Q1 2023 | $4,012,299 | +5.0% | 2,711,013 | 0.0% | 0.08% | +8.2% |
Q4 2022 | $3,822,528 | -48.7% | 2,711,013 | 0.0% | 0.07% | -47.1% |
Q3 2022 | $7,455,000 | -41.5% | 2,711,013 | 0.0% | 0.14% | -40.3% |
Q2 2022 | $12,742,000 | -3.3% | 2,711,013 | 0.0% | 0.23% | +7.9% |
Q1 2022 | $13,176,000 | -19.0% | 2,711,013 | 0.0% | 0.21% | +2.4% |
Q4 2021 | $16,266,000 | -11.0% | 2,711,013 | 0.0% | 0.21% | +4.0% |
Q3 2021 | $18,272,000 | -16.1% | 2,711,013 | 0.0% | 0.20% | -8.6% |
Q2 2021 | $21,769,000 | -19.8% | 2,711,013 | 0.0% | 0.22% | -13.4% |
Q1 2021 | $27,137,000 | -8.2% | 2,711,013 | 0.0% | 0.25% | -1.9% |
Q4 2020 | $29,550,000 | +23.9% | 2,711,013 | 0.0% | 0.26% | -13.7% |
Q3 2020 | $23,857,000 | -59.0% | 2,711,013 | 0.0% | 0.30% | -63.3% |
Q2 2020 | $58,124,000 | -42.2% | 2,711,013 | 0.0% | 0.82% | -51.6% |
Q1 2020 | $100,497,000 | -34.2% | 2,711,013 | 0.0% | 1.69% | -22.5% |
Q4 2019 | $152,711,000 | +82.6% | 2,711,013 | 0.0% | 2.18% | +37.4% |
Q3 2019 | $83,635,000 | +105.9% | 2,711,013 | 0.0% | 1.59% | +152.3% |
Q2 2019 | $40,611,000 | – | 2,711,013 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |